| Literature DB >> 29415717 |
W H van Harten1, N Goedbloed2, A H Boekhout2, S Heintzbergen2.
Abstract
BACKGROUND: In general, patients with a cancer suspicion visit the hospital multiple times before diagnosis is completed. Using various "operations management" techniques a few fast track diagnostic services were implemented in the Netherlands Cancer Institute (NKI) in 2006. Growing patient numbers and increasing process complexity, led to diminished service levels. To decrease the amount of patient visits and to extend these services beyond the (obvious) breast cancer services, fast track diagnostics is now implemented for all 18 cancer types that present with a frequency of minimally one per week.Entities:
Keywords: Cancer care facilities; Critical pathways; Health services; Oncology service hospital, Organizational, Organizational management, Operations management; Patient centered care; Patient logistics, Early cancer detection
Mesh:
Year: 2018 PMID: 29415717 PMCID: PMC5804070 DOI: 10.1186/s12913-018-2868-5
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Fig. 1The access time (date the appointment was made to first face to face contact), and throughput time (first face to face contact to consultation in which diagnosis and first treatment advice is provided), was measured before redesigning the diagnosis process, and repeated after implementation of fast track diagnostics
Base measurement
| Number of patients | Mean throughput time (workdays) | Mean number of hospital visits | |
|---|---|---|---|
| Colon/Rectum | 5 | 12,4 | 3 |
| Breast | 125 | 3,0 | 1,4 |
| Head and Neck | 16 | 17,2 | 4,6 |
| Bladder | 9 | 17,6 | 4,1 |
| Prostate | 12 | 11,3 | 2,3 |
| Total | 167 | 6,0 | 2,0 |
Fig. 2Mean throughput time in prostate diagnostics before and after fast track diagnostics implementation.
^MDO= multidisciplinary physicians meeting.
~MRI=magnetic resonance imaging.
# Multidisciplinary physicians meeting was not registered in baseline measurement (estimated time between MRI and MDO is 3 workdays).
*In patients without MRI indication a blood test is done before consult physician assistant (same day)
Fig. 3Mean throughput time in colon/rectum know cancer diagnostics before (measured total time, but guessed differentiated throughput time) and after fast track diagnostics implementation.
^MDO= multidisciplinary physicians meeting.
~MRI=magnetic resonance imaging
Mean Throughput time (workdays) in post measurement
| After 3 months | After 3–6 months | ||||||
|---|---|---|---|---|---|---|---|
| Objective for 95% | Number of patients | Mean access time (workdays) | Mean throughput time (workdays) | Number of patients | Mean access time (workdays) | Mean throughput time (workdays) | |
| Colon/Rectum cancer suspicion | 3 | 7 | 8 | 3 | 7 | 6,7 | 3 |
| Colon/Rectum known cancer | 1 | 34 | 7,4 | 1 | 33 | 7,2 | 1 |
| Cervix | 7 | 7 | 6,5 | 4,3 | 4 | 10,8 | 4,5 |
| Ovary | 7 | 13 | 10,5 | 5 | 5 | 13 | 4,3 |
| Breast | 1 | 244 | 5,3 | 1* | 247 | 5,1 | 1* |
| Head and Neck | 11 | 77 | 7 | 7,6 | 56 | 7,7 | 9,5 |
| Liver | 1 | 19 | 7,6 | 1,2 | 29 | 7,8 | 1 |
| Esophagus/stomach | 1 | 11 | 7,7 | 1 | 30 | 7,3 | 1,3 |
| Kidney | 1 | 32 | 12,4 | 1 | 32 | 7,8 | 1 |
| Bladder | 6 | 42 | 10,6 | 6 | 49 | 9,2 | 5,3 |
| Prostate | 1 to 6$ | 132 | 12,7 | 4,5 | 135 | 16,2^ | 4 |
| Sarcoma | 7 | 45 | 8,7 | 11 | 40 | 8,8 | 11,6 |
| Suspicious skin spot | 6 | 16 | 11,3 | 6 | 12 | 7,8 | 6,5 |
| Total | 679 | 8,2 | 3,4 | 679 | 8,7 | 3,3 | |
$Depending on if diagnosis with MRI is necessary
*Provisionally diagnosis, PA confirmation within 5 workdays
^Long access time due to patients who just had a biopsy elsewhere. For good imaging we need at least 6 weeks between biopsy and MRI
Percentage of slot use of fast track reserved capacity after 6 months
| Slot use of fast track reserved capacity | ||||||||
|---|---|---|---|---|---|---|---|---|
| After 3 months | After 6 months | |||||||
| MRI | CT | Echo | PET | MRI | CT | Echo | PET | |
| Colon/Rectum known cancera | 54% | 31% | 54% | 46% | ||||
| Cervix | 16% | 25% | 12% | 17% | ||||
| Endometrium | ||||||||
| Ovary | ||||||||
| Vagina | ||||||||
| Vulva | ||||||||
| Head and Neck | 73% | 46% | 80% | 67% | 65% | 32% | 67% | 47% |
| Liver | 42% | 57% | ||||||
| Esophagus/stomacha | 25% | 17% | 33% | 17% | 33% | 43% | ||
| Kidneya | 23% | 15% | 31% | 23% | ||||
| Bladder | 67% | 60% | ||||||
| Prostate | 73% | 89% | ||||||
| Sarcoma | 100%b | 48% | 29% | 56% b | 75% | 42% | ||
aOnly one slot reserved, therefore less capacity is not possible
bExtra MRI capacity assigned in response to results after 3 months